Levetiracetam‐responsive paroxysmal exertional dyskinesia in a Welsh Terrier

Autor: Green, Sherril; Olby, Natasha
Sprache: Englisch
Veröffentlicht: 2021
Quelle: PubMed Central (PMC)
Online Zugang: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995356/
http://www.ncbi.nlm.nih.gov/pubmed/33638219
http://dx.doi.org/10.1111/jvim.16068
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995356/
https://doi.org/10.1111/jvim.16068
Erfassungsnummer: ftpubmed:oai:pubmedcentral.nih.gov:7995356

Zusammenfassung

A 5‐and‐a‐half‐year old, 9‐kg, spayed, female Welsh Terrier presented with a 12 month history of paroxysmal exertion‐induced dyskinesia (PED) characterized by recurrent episodes of involuntary hyperkinetic movements, abnormal muscle tone, and contractions triggered by exercise. A single episode occurred within 2 hours after exercise, lasted from 7 to 10 minutes, and resolved without treatment. The owner sought treatment for the dog when the episodes began to last longer (20‐30 minutes), and occurred as long as 2.5 to 8 hours after exercise. Diazepam administered intranasally at the start of an episode promptly alleviated the symptoms. Maintenance therapy with levetiracetam proved effective, such that the dog was gradually returned to exercise. However, attempts to wean the dog off the drug resulted in reoccurrence. Although the pathophysiology of PED is not fully understood, the clinical presentation and the positive response to antiepileptic therapy highlight the overlap between disease pathways in epilepsy and PED in dogs.